A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO)

The requested reference [4663dc21ef5ccc496cd55504a8df5de1c4186c45] no longer exists in our database. It has been replaced by the current reference: [c904c79186c34593144def3f9deb358238e895e9]

Authors
Category Primary study
JournalCancer Research
Year 2020
This article has no abstract
Epistemonikos ID: 394a700884089a0589e742e8865b2e5a1ac63e9e
First added on: Feb 12, 2025